ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$177.45

Market cap

$26.85B

P/E Ratio

32.15

Dividend/share

N/A

EPS

$5.52

Enterprise value

$28.22B

?
Relative Growth: Rel. Growth: 47
Relative Strength: Rel. Strength: 88
Relative Valuation: Rel. Valuation: 57
Relative Profitability: Rel. Profitability: 97

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
Illumina's EPS has surged by 191% YoY
ILMN's net income has soared by 188% year-on-year
The stock's price to earnings (P/E) is 67% more than its last 4 quarters average of 19.6
The quick ratio has contracted by 23% from the previous quarter and by 10% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com
Peers: PACB A TMO DHR

Key stats

What are the main financial stats of ILMN

ILMN stock price

How has the Illumina stock price performed over time
Intraday
-2.02%
1 week
7.59%
1 month
8.89%
1 year
85.99%
YTD
35.29%
QTD
43.96%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.39B
Gross profit
$2.91B
Operating income
$851M
Net income
$853M
Gross margin
66.2%
Net margin
19.4%
ILMN's net income has soared by 188% year-on-year
Illumina's net margin has surged by 187% YoY
The operating income has increased by 5% from the previous quarter
Illumina's operating margin has increased by 4.3% from the previous quarter

Price vs fundamentals

How does ILMN's price correlate with its fundamentals

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
ILMN P/E details
P/E
32.15
P/B
10.14
P/S
6.18
EV/EBIT
24.33
EV/EBITDA
19.74
EV/Sales
6.42
Illumina's EPS has surged by 191% YoY
The stock's price to earnings (P/E) is 67% more than its last 4 quarters average of 19.6
The price to book (P/B) is 64% higher than the 5-year quarterly average of 6.3 and 54% higher than the last 4 quarters average of 6.7
The equity has increased by 13% YoY
ILMN's P/S is 62% above its last 4 quarters average of 3.9 but 9% below its 5-year quarterly average of 6.9

Efficiency

How efficient is Illumina business performance
The company's return on assets has surged by 185% YoY
The ROE has soared by 173% YoY but it has contracted by 2.6% from the previous quarter
Illumina's return on sales has decreased by 3.3% QoQ

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 69% more than the total liabilities
The quick ratio has contracted by 23% from the previous quarter and by 10% YoY
The current ratio has contracted by 16% from the previous quarter and by 6% YoY
Illumina's debt is 8% lower than its equity
The debt to equity is down by 14% year-on-year
The equity has increased by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.